August 18, 2026

In this video interview, Dr. Monika Joshi discusses the EA8231 trial for metastatic bladder cancer and encourages more sites to join the 70+ sites currently participating

August 17, 2026

The Summer 2026 advocacy blog Considering Clinical Trials is now available

August 3, 2026

The July 2026 News from ECOG-ACRIN blog is now available

July 9, 2026

Podcast: ASCO Post includes updated STAMP (EA6174) Merkel cell carcinoma data in its ASCO26 highlights, applauding cooperative groups for their ability to study rare cancers

June 29, 2026

The June 2026 News from ECOG-ACRIN blog is now available

June 4, 2026

A new exploratory analysis from STAMP (EA6174) on aggressive Merkel cell cancer draws attention at ASCO 2026

June 2, 2026

EA5142, an ALCHEMIST trial, adds to the knowledge base about optimal timing of adjuvant immunotherapy in non-small cell lung cancer

June 2, 2026

WATCH: Dr. Jamie Chaft discusses the results of ALCHEMIST EA5142, a randomized phase 3 study of nivolumab after surgery and adjuvant chemotherapy in non-small cell lung cancer

June 1, 2026

JAMA publishes ALCHEMIST EA5142 results: Nivolumab does not further reduce the risk of recurrence in patients with resected non-small cell lung cancer

ECOG-ACRIN Cancer Research Group